D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/15780844
Conclusion of this study
These findings 1) indicate that risperidone and olanzapine efficacy might be augmented with D-serine adjuvant treatment; 2) confirm D-serine efficacy against main schizophrenia symptom domains; and 3) warrant the assessment of D-serine antipsychotic monotherapy for this illness.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study